Robbie Marcus Analyst Performance

Medtech Senior Analyst at JPMorgan Chase & Co.

Robbie Marcus is a stock analyst at JPMorgan Chase & Co. focused in the medical sector, covering 18 publicly traded companies. Over the past year, Robbie Marcus has issued 19 stock ratings, including buy, hold, and sell recommendations. While full access to Robbie Marcus' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Robbie Marcus' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 30 Last 8 Years
Buy Recommendations: 60.00% 18 Buy Ratings
Companies Covered: 18 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	60.0%	18 ratings
Hold	26.7%	8 ratings
Sell	13.3%	4 ratings

Out of 30 total stock ratings issued by Robbie Marcus at JPMorgan Chase & Co., the majority (60.0%) have been Buy recommendations, followed by 26.7% Hold and 13.3% Sell.

Best & Worst Calls

Best Call
000.0%
INGN
Jun 2017
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
GKOS
Aug 2019
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	55.6% of companies on NASDAQ	10 companies
NYSE	44.4% of companies on NYSE	8 companies

Robbie Marcus, an analyst at JPMorgan Chase & Co., currently covers 18 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 17 companies	94.4%
	Miscellaneous 1 company	5.6%

Robbie Marcus of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

Industry	Percentage
MED INSTRUMENTS 8 companies	44.4%
MED/DENTAL - SUPP 3 companies	16.7%
MED PRODUCTS 3 companies	16.7%
MEDICAL INFO SYS 2 companies	11.1%
HEALTH INFORMATION SERVICES 1 company	5.6%
HOLDING & OTHER INVESTMENT OFFICES 1 company	5.6%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
HTFL Heartflow	9/2/2025	Initiated Coverage	$31.50	$36.00	Overweight
COO Cooper Companies	8/28/2025	Lower Price Target	$64.44	$66.00	Neutral
INSP Inspire Medical Systems	8/5/2025	Downgrade	$130.79	$110.00	Neutral
EW Edwards Lifesciences	7/25/2025	Boost Price Target	$79.92	$85.00	Neutral
COO Cooper Companies	5/30/2025	Reiterated Rating	$79.96	$76.00	Neutral
NPCE NeuroPace	5/14/2025	Boost Price Target	$16.08	$16.00	Overweight
CVRX CVRx	5/9/2025	Reiterated Rating	$7.79	$7.00	Underweight
IART Integra LifeSciences	5/6/2025	Lower Price Target	$13.27	$12.00	Underweight
INSP Inspire Medical Systems	5/6/2025	Lower Price Target	$149.88	$195.00	Overweight
ZBH Zimmer Biomet	5/6/2025	Lower Price Target	$90.65	$105.00	Overweight
CNMD CONMED	5/1/2025	Lower Price Target	$56.06	$58.00	Neutral
RXST RxSight	4/4/2025	Reiterated Rating	$16.21	$17.00	Underweight
MMSI Merit Medical Systems	3/28/2025	Initiated Coverage	$103.27	$120.00	Overweight
COO Cooper Companies	3/7/2025	Lower Price Target	$84.04	$110.00	Overweight
RXST RxSight	2/26/2025	Lower Price Target	$27.57	$40.00	Overweight
BAX Baxter International	2/21/2025	Lower Price Target	$33.49	$36.00	Neutral
CNMD CONMED	2/6/2025	Downgrade	$74.35	$70.00	Neutral
SYK Stryker	1/29/2025	Boost Price Target	$394.92	$445.00	Overweight
ISRG Intuitive Surgical	1/24/2025	Boost Price Target	$608.66	$675.00	Overweight

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.